Acquisition | CLEMENTIA PHARMACEUTICALS INC | 18th April 2019

Due to the acquisition of CLEMENTIA PHARMACEUTICALS INC by IPSEN SA, the following treatment will be applied to the following indices.

Solactive US Extended Broad Market Index

• CLEMENTIA PHARMACEUTICALS INC will be removed from the Index.
• The weight of CLEMENTIA PHARMACEUTICALS INC based on its last close price will be distributed pro rata to remaining Index constituents.
• Effective Date (open): 04/18/2019.